Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed, often without clear indications. There are conflicting data on its association with mortality risk and hepatic decompensation in cirrhotic patients. Furthermore, PPI users and PPI exposure in some studies have been poorly defined with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: De Roza, Marianne Anastasia, Kai, Lim, Kam, Jia Wen, Chan, Yiong Huak, Kwek, Andrew, Ang, Tiing Leong, Hsiang, John Chen
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Cohort Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737311/
https://ncbi.nlm.nih.gov/pubmed/31543684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i33.4933
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares